Diurnal Group Share Forecast, Price & News

Diurnal Group (LON:DNL) Frequently Asked Questions

What stocks does MarketBeat like better than Diurnal Group?

Wall Street analysts have given Diurnal Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Diurnal Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Diurnal Group's earnings last quarter?

Diurnal Group plc (LON:DNL) posted its quarterly earnings results on Tuesday, September, 15th. The company reported ($4.30) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($6.70) by $2.40.
View Diurnal Group's earnings history.

How has Diurnal Group's stock been impacted by Coronavirus (COVID-19)?

Diurnal Group's stock was trading at GBX 34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DNL stock has increased by 62.1% and is now trading at GBX 55.10.
View which stocks have been most impacted by COVID-19.

Who are Diurnal Group's key executives?

Diurnal Group's management team includes the following people:

• Dr. Martin Whitaker B.Sc., BSc, Ph.D., CEO & Exec. Director
• Mr. Richard Edward Bungay A.C.A., B.Sc., BSc, ACA, CFO, Company Sec. & Director (Age 52, Pay $364k)
• Prof. Richard Ross, Chief Scientific Officer & Exec. Director
• Mr. Daniel Margetson, Director of Chemistry, Manufacturing & Controls

Who are some of Diurnal Group's key competitors?

Some companies that are related to Diurnal Group include The Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), Science in Sport (SIS), BioSyent (RX), Shield Therapeutics (STX), The Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Venture Life Group (VLG), WeedMD (WMD), Cipher Pharmaceuticals (CPH), Acerus Pharmaceuticals (ASP) and Indiva (NDVA).
View all of DNL's competitors.

What other stocks do shareholders of Diurnal Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diurnal Group investors own include Allena Pharmaceuticals (ALNA), Abercrombie & Fitch (ANF), Ampliphi Biosciences (APHB), Cerecor (CERC), Revolution Lighting Technologies (RVLT), Spero Therapeutics (SPRO), SRC Energy (SRCI), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and AcelRx Pharmaceuticals (ACRX).

What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 55.10.

How much money does Diurnal Group make?

Diurnal Group has a market capitalization of £93.07 million and generates £4.37 million in revenue each year.

How many employees does Diurnal Group have?

Diurnal Group employs 29 workers across the globe.

What is Diurnal Group's official website?

The official website for Diurnal Group is www.diurnal.co.uk.

Where are Diurnal Group's headquarters?

Diurnal Group is headquartered at Heath Park, CARDIFF, CF14 4UJ, United Kingdom.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.